Navigation Links
BioElectronics Corporation Announces Initiative for UK and German Markets
Date:7/12/2012

FREDERICK, Md., July 12, 2012 /PRNewswire/ -- BioElectronics Corporation ("BioElectronics") (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced the formation of ActiPatch Plc, an entity through which BioElectronics proposes to conduct all sales, marketing, advertising and distribution functions for BioElectronics' medical devices in the German (81.3 million people) and United Kingdom (60 million people) markets.  BioElectronics will manage the operations of ActiPatch Plc, which will focus on promoting Allay for menstrual pain and the ActiPatch products for musculoskeletal pain.

"The German and UK markets are ideal markets for sustained direct to consumer advertising campaigns for our home use pain devices," said Andrew Whelan, CEO and President, BioElectronics.  Menstrual pain affects nearly 50% of women capable of reproducing and a recent EU Commission study suggests that 14.2 million people in Germany and 9.6 million in the UK suffered pain in their lower or upper back in the previous week.  BioElectronics' products have broad market clearances in the EU and UK where shortwave therapy is well understood and widely used by medical professionals.

"We have engaged a London-based team to put together the new company and coordinate the proposed PLUS-quoted application process," Mr. Whelan said.  The Corporate Adviser, SVS Securities Plc, is leading the team which includes the accounting firm, Bennett Brooks & Co, Ltd. and the law firm of Irvine and Partners.

About SVS Securities Plc
SVS Securities Plc (www.svssecurities.com) focuses on advising and assisting small to mid-sized companies in growth markets who may seek to raise funds.

About BioElectronics Corporation
BioElectronics is a developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care method to reduce soft tissue pain and swelling. The Company also manufactures HealFast™ Therapy (http://www.healfasttherapy.com) which is sold by eMarkets Group.  For more information, please visit www.bielcorp.com.

For media inquiries, please contact:

Paul Knopick
940.262.3584
pknopick@eandecommunications.com
E&E Communications


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
2. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
3. BioElectronics ActiPatch Reduces Muscle Soreness in Runners
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
6. Luminex Corporation Announces Agreement to Acquire GenturaDx
7. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
8. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
9. Celladon Corporation Receives Notice of Allowance from European Patent Office
10. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
11. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
(Date:8/7/2017)... Ind. , Aug. 7, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that its Board of Directors has ... for the third quarter of 2017. ... be paid on or about October 27, 2017 to stockholders ... 22, 2017.  Future declarations of dividends are subject to approval ...
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... ... The Women’s Choice Award, a growing platform that gives a voice to ... Award. The identification by women of an effective new migraine relief product ... In a survey taken by the Women’s Choice Award organization, nine out of ten ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western North Carolina’s only ... popular international aesthetics conference for medical professionals about the positive impact Juliet™ ... his growing practice. , Dr. George K. Ibrahim shared the results ...
(Date:8/22/2017)... ... ... six years, Lightning Labels has sent out a call for users of its custom label ... of their designs. Submissions this year were open from May 18 to July 1 and ... of the sixth annual Photo Contest, along with the prizes they've received:, ...
(Date:8/22/2017)... ... 2017 , ... Nurses at Apple Rehab Watch Hill , a nursing ... and certification in Closed Pulse Irrigation™ (CPI) for wound care. This qualifies ... Centers for Medicare and Medicaid Services, to have a CPI machine that will provide ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... “To Walk ... radioman on a B17 bomber named Edward Koontz. “To Walk Away” is the creation ... Scranton, who has published over two hundred manuscripts in chemistry and religion, as well ...
Breaking Medicine News(10 mins):